MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1871520622666220513114205

Медицинская библиотека · Anti-cancer agents in medicinal chemistry · 2023

Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors Against Chronic Myeloid Leukemia Cells.

Cort-Donmez Aysegul, Olgen Sureyya, Guner Ersin, Akgun-Cagliyan Gulsum, Hanikoglu Ferhat, Tunc-Ata Melek, Kilic-Toprak Emine

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Src family tyrosine kinases play a potential role in Bcr-Abl-induced leukemogenesis. Src kinase inhibitors are reported as selective inhibitors of chronic myeloid leukemia.

OBJECTIVE

Since Src kinase inhibitors have an inhibitive effect on chronic myeloid leukemia, indole derivatives (C-1, C-2, C-3) previously found as potent inhibitors of Src kinase were tested against chronic myeloid leukemia in this study.

METHODS

Cell viability of K562 and R/K562 cells, antiproliferative and antioxidant effects, and inhibition profiles of Bcr-Abl kinase of indole derivatives were determined compared to dasatinib and imatinib.

RESULTS

The results showed that compounds affected cell proliferation and decreased the levels of Bcr/Abl. These results confirmed that the antileukemic activity of compounds was related to Bcr/Abl expression. Docking studies also presented that compounds are inhibitors of both Src and Abl kinases. Calculation of drug-like properties showed that compounds could be potential drug candidates.

CONCLUSION

Among indole-2-on derivatives, previously identified as Src kinase inhibitors, C-2 has been discovered to be a strong anticancer drug that is active against susceptible and resistant K562 cell lines and induces apoptosis.

Для цитирования: Cort-Donmez Aysegul, Olgen Sureyya, Guner Ersin, Akgun-Cagliyan Gulsum, Hanikoglu Ferhat, Tunc-Ata Melek, Kilic-Toprak Emine. Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors Against Chronic Myeloid Leukemia Cells.. Anti-cancer agents in medicinal chemistry. 2023. DOI: 10.2174/1871520622666220513114205.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.